Login / Signup

Efficacy of adjuvant CDK4/6 inhibitors in Hormone Receptor-positive breast cancer: a systematic review and meta-analysis.

Yakup ErgünMutlu DoganGokhan UcarPınar KaracinCengiz Karacin
Published in: Expert opinion on pharmacotherapy (2023)
Addition of CDK4/6 inhibitors to standard ET in the adjuvant treatment of HR-positive/HER2-negative early-stage BC improves iDFS.
Keyphrases
  • early stage
  • positive breast cancer
  • cell cycle
  • sentinel lymph node
  • squamous cell carcinoma
  • cell proliferation
  • radiation therapy
  • combination therapy
  • rectal cancer
  • locally advanced